SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-20-000256
Filing Date
2020-03-24
Accepted
2020-03-24 16:17:56
Documents
2
Group Members
ARUN KUMAR PILLAIGHIATH M. SUKHTIANGMS VENTURES & INVESTMENTS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 12 ss169743_sc13da.htm SC 13D/A 95448
2 JOINT FILING AGREEMENT ss169743_ex9901.htm EX-99.1 7447
  Complete submission text file 0000947871-20-000256.txt   104619
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Subject) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-89495 | Film No.: 20738579
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 36 ROBINSON ROAD, #13-01 CITY HOUSE SINGAPORE U0 068877
Business Address 36 ROBINSON ROAD, #13-01 CITY HOUSE SINGAPORE U0 068877 962 6 582 7999
BioLexis Pte Ltd. (Filed by) CIK: 0001716335 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A